Aurion BioTech presents cell therapy findings with published clinical data

Greg Kunst, president and CEO of Aurion BioTech, shares a company update on endothelial cell therapy trials, clinical plans and upcoming data.

Related Videos

Related Content

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

September 22nd 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

September 13th 2023

Bridging the gap: Real World Ophthalmology connects young ophthalmologists with invaluable knowledge and expertise

September 19th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

September 13th 2023

Otsuka, ShapeTX collaborate to develop novel AAV gene therapies for ocular diseases

September 9th 2023

Neurophth gets Australian approval for ophthalmic gene therapy

September 6th 2023

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

September 22nd 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

September 13th 2023

Bridging the gap: Real World Ophthalmology connects young ophthalmologists with invaluable knowledge and expertise

September 19th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

September 13th 2023

Otsuka, ShapeTX collaborate to develop novel AAV gene therapies for ocular diseases

September 9th 2023

Neurophth gets Australian approval for ophthalmic gene therapy

September 6th 2023

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

September 22nd 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

September 13th 2023

Bridging the gap: Real World Ophthalmology connects young ophthalmologists with invaluable knowledge and expertise

September 19th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

September 13th 2023

Otsuka, ShapeTX collaborate to develop novel AAV gene therapies for ocular diseases

September 9th 2023

Neurophth gets Australian approval for ophthalmic gene therapy

September 6th 2023

Related Content

Advertisement

---

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

Article

---

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Podcast

---

Bridging the gap: Real World Ophthalmology connects young ophthalmologists with invaluable knowledge and expertise

Article

---

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

Podcast

---

Otsuka, ShapeTX collaborate to develop novel AAV gene therapies for ocular diseases

Article

---

Neurophth gets Australian approval for ophthalmic gene therapy

Article